hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
BACKGROUND: Hypoxia is an important mechanism of treatment resistance in head and neck squamous cell carcinoma (HNSCC). MicroRNAs are short noncoding RNAs that regulate multiple mRNAs and are frequently dysregulated in cancer. The authors have investigated the role of 3 microRNAs, including the hyp...
Main Authors: | Gee, H, Camps, C, Buffa, F, Patiar, S, Winter, S, Betts, G, Homer, J, Corbridge, R, Cox, G, West, C, Ragoussis, J, Harris, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2010
|
Títulos similares
-
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
por: Camps, C, et al.
Publicado: (2008) -
The role of hypoxia-inducible MIR-210 in the biology and prognosis of clear cell kidney cancer
por: McCormick, I, et al.
Publicado: (2011) -
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
por: Winter, S, et al.
Publicado: (2007) -
Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.
por: Betts, G, et al.
Publicado: (2013) -
Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
por: Betts, G, et al.
Publicado: (2013)